In contrast, Tagami et al. [19] performed propensity score and instrumental variable analyses using a Japanese nationwide administrative database (matched cohort of 1140 pairs) and reported that treatment with recombinant thrombomodulin did not reduce mortality among patients with pneumonia-associated DIC. This evidence concerns the gene THBD and pneumonia.